Protara Therapeutics Announces Appointment of Martín Sebastian Olivo, M.D. as Chief Medical Officer

NEXT STORY
Predictmedix Announces Technology Deployments at Major Office Towers in Calgary and Edmonton in Partnership With Aspen Properties
PREV STORY
Arch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Krystal Biotech Announces Virtual Presentation of Pre-clinical Data on KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency at ESGCT

author_avatar
NASDAQ Market News

Nirsevimab shows positive topline results in RSV Phase 2/3 MEDLEY trial

author_avatar
NASDAQ Market News

Epizyme Announces Path Toward Tazemetostat Registration in Epithelioid Sarcoma and Reports New Clinical Data to be Presented at ASCO

Path Toward Submission for Accelerated Approval Tazemetostat Demonstrates Clinically Meaningful Activity in Epithelioid Sarcoma; ...

author_avatar
NASDAQ Market News